Matthijs Versteegh, PhD (Utrecht, The Netherlands, 1984) is director at the institute for Medical Technology Assessment (iMTA) at Erasmus University of Rotterdam. Matthijs holds an undergraduate in health sciences, and a master (cum laude) in science & technology studies (Maastricht University). He obtained his PhD in health economics on quantifying quality of life for economic evaluations of health from Erasmus University of Rotterdam. After completing his PhD, Matthijs worked for consultancy firm Ecorys (Dutch office) on projects for the European Commission (DG SANCO), the World Health Organisation (in Moldova and Kazakhstan), the World Bank (in India) and large regional variation studies for the Dutch board of Health Insurance (Zorginstituut Nederland). Matthijs is a member of the EuroQoL research foundation and the ‘Jonge Zorgdenktank’.
T.A. Kanters, J.J. Brugts, O.C. Manintvelt & M.M. Versteegh (2021). Burden of providing informal care for patients with atrial fibrillation. Value in Health, 24 (2), 236-243. doi: 10.1016/j.jval.2020.09.011
J.J. Brugts, J.F. Veenis, S.P. Radhoe, G. LInsssen, M. Van Gent, C.J.W. Borleffs, J. van Ramhorst, P. van Pol, R. Tukkie, R. Spee, M. Emans, W. Kok, V. van Halm, L. Handoko, S. Beeres, M. Post, E. Boersma, M.J. Lenzen, O.C. Manintveld, H. Koffijberg, P.H.M. van Baal, M.M. Versteegh, T. Smilde, L. van Heerebeek, M. Rienstra, A. Mosterd, P. Delnoy, F.W. Asselbergs, H. Brunner-La Rocca & R. de Boer (2020). A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial. Netherlands Heart Journal, 28 (1), 16-26. doi: 10.1007/s12471-019-01341-9
M.F. Jonker, B. Donkers, L.M.A. Goossens, R.J. Hoefman, L.J. Jabbarian, E. De Bekker-Grob, M.M. Versteegh, G. Harty & S. Wong (2020). Summarizing Patient Preferences for the Competitive Landscape of (Multiple Sclerosis) Treatment Options. Medical Decision Making, 40 (2), 198-211. doi: 10.1177/0272989X19897944
S. de Groot, W.K. Redekop, M.M. Versteegh, S. Sleijfer, E. Oosterwijk, L.A.L.M. Kiemeney & C.A. Uyl - de Groot (2018). Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma. Quality of Life Research, 27, 115-124. doi: 10.1007/s11136-017-1704-4
D.T. Arnold, D. Rowen, M.M. Versteegh, A. Morley, C.E. Hooper & N.A. Maskell (2015). Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma. Health and Quality of Life Outcomes, 13 (6). doi: 10.1186/s12955-014-0196-y